cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)International Federation of Gynec ology and Obstetrics (FIGO) stage of IA 2, IB1, or IIA1 2)Age of over 20 years 3)Those with adequate organ function 4)Those who have given written informed consent
Exclusion criteria
Exclusion criteria: 1)Tumor diameter>40mm 2)Those with serious complication 3)Those with concomitant active malignancy 4)Those who are inadequate to be enrolled in the protocol study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological evaluation of surgical completion | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical adverse effect(blood loss, blood transfusion, postoperative complications) | — |
Countries
Japan
Contacts
Asahikawa Medical University Department of Obstetrics and Gynecology